194 results on '"Nakahara, Mai"'
Search Results
2. Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients
3. Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
4. Higher Indocyanine Green Retention Is Associated with Improved Prognosis in Patients with Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization
5. Tim4, a macrophage receptor for apoptotic cells, binds polystyrene microplastics via aromatic-aromatic interactions
6. Prognosis of probable autoimmune hepatitis patients: a single-center study in Japan
7. Effect of pegylated interferon alfa-2a in HBeAg-negative chronic hepatitis B during and 48 weeks after off-treatment follow-up: the limitation of pre-treatment HBsAg load for the seroclearance of HBsAg
8. Hepatocyte growth factor ameliorates methylglyoxal-induced peritoneal inflammation and fibrosis in mouse model
9. A case of latent heterozygous Fabry disease in a female living kidney donor candidate
10. A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete response
11. 亜鉛製剤の長期投与中に急激な血球減少・末梢神経障害を生じた肝硬変患者の一例
12. Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival
13. Predictors of therapeutic response to peginterferon α‑2a and nucleos(t)ide analog combination therapy for HBeAg‑negative chronic hepatitis B: 1‑year follow‑up after treatment
14. Higher indocyanine green retention is associated with improved prognosis in patients with hepatocellular carcinoma treated with transarterial chemoembolization
15. Hepatocellular carcinoma treated with radical resection after endoscopic diagnosis of the extent of bile duct invasion: A case report.
16. Effectiveness of Edoxaban in Portal Vein Thrombosis Associated with Liver Cirrhosis
17. Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir
18. L-carnitine reduces hospital admissions in patients with hepatic encephalopathy
19. Hepatocellular carcinoma treated with radical resection after endoscopic diagnosis of the extent of bile duct invasion: A case report
20. Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy
21. Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease
22. Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy
23. Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
24. Higher indocyanine green retention rates predicted improved prognoses in hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization
25. Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
26. Clinical features of hepatic dysfunction caused by immune checkpoint inhibitors and treatment of refractory cases
27. Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells
28. Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
29. Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines
30. Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells
31. Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study
32. Gene-trap mutagenesis using Mol/MSM-1 embryonic stem cells from MSM/Ms mice
33. Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up
34. Multimodal treatment involving molecular targeted agents and on‑demand transcatheter arterial chemoembolization for advanced hepatocellular carcinoma: A case report
35. Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study
36. Database for exchangeable gene trap clones: Pathway and gene ontology analysis of exchangeable gene trap clone mouse lines
37. Galectin‑9 suppresses the tumor growth of colon cancer in vitro and in vivo
38. Association between microRNA‑527 and glypican‑3 in hepatocellular carcinoma
39. Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo
40. Improvement of some physicochemical properties of arundic acid, (R)-(−)-2-propyloctanonic acid, by complexation with hydrophilic cyclodextrins
41. A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete response
42. Identification of microRNA associated with the elimination of hepatitis C virus genotype 1b by direct‐acting antiviral therapies
43. L-carnitine reduces hospital admissions in patients with hepatic encephalopathy
44. A case of latent heterozygous Fabry disease in a female living kidney donor candidate
45. Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
46. Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis
47. Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct‑acting antiviral treatment: All Kagawa Liver Disease Group Study
48. The Effect of Gemcitabine on Cell Cycle Arrest and microRNA Signatures in Pancreatic Cancer Cells
49. Changes in body composition and low blood urea nitrogen level related to an increase in the prevalence of fatty liver over 20 years: A cross‐sectional study.
50. Efficacy of combined modality therapy with sorafenib following hepatic arterial injection chemotherapy and three‑dimensional conformal radiotherapy for advanced hepatocellular carcinoma with major vascular invasion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.